New shingles vaccine Z-1018 takes on shingrix in Head-to-Head trial
⭐️ VACCINE ⭐️
Ongoing
This study tests a new shingles vaccine called Z-1018 in about 764 healthy adults aged 50 and older. It compares Z-1018 to the current vaccine, Shingrix, to see if it is safe and triggers a strong immune response. The trial is in early phases (1 and 2), so the main focus is on sa…
Phase: PHASE1, PHASE2 • Sponsor: Dynavax Technologies Corporation • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 13:00 UTC